Phase 4Active, not recruiting

Pharmacokinetics of Transdermal Metronidazole

Impact of Formulation on the Pharmacokinetics of Micropatch-assisted Delivery of Metronidazole

Sponsor
University of Iowa (Academic or other)
Enrollment
24 planned
Conditions
Healthy
Interventions
Metronidazole 0.75% Topical Gel; Metronidazole 0.75% Topical Cream; Transdermal water loss measurement; Electrical Resistance; Skin color measurement; Micropatch application
Ages
adults, older adults
Registry
NCT05929794

Full record on ClinicalTrials.gov

From the registry

This is a crossover pharmacokinetic clinical study in healthy volunteers to compare metronidazole delivery through skin when a gel or cream metronidazole product is applied to skin treated with a micropatch.

Primary outcomes

  • Measurement of maximum serum metronidazole concentration (Cmax)
  • Time of maximum serum metronidazole concentration (Tmax)
  • Area under the serum-concentration curve from 0-120 hours

History

  1. Study completion expected

  2. Last registry update

  3. Primary completion

  4. Started

  5. Registered